Jiangsu Yuwell Medical Equipment & Supply Co., Ltd.
Yuwell
Yuwell Medical is China's fastest-growing home medical device manufacturer and a rising global competitor, founded in 1998 in Danyang, Jiangsu, China. With annual revenue of ¥7.955 billion, the company operates 5 major production bases and 8 R&D centers across China, Germany, USA, and Taiwan. Yuwell covers nearly every home medical device subcategory from oxygen concentrators to blood glucose monitors.
Strengths: Broadest product portfolio across home medical subcategories 4.1-4.9; overseas revenue surged 29.86% to ¥1.232B in 2025; massive R&D investment in CGM and next-gen health monitors; global manufacturing network spanning China, Germany, USA, and Taiwan.
Weaknesses: Net profit dropped 17.94% due to aggressive marketing spend (¥1.763B sales expenses); faces intense domestic price competition; brand recognition still lower than Western incumbents outside China.Read More ▼Show Less ▲
Strengths: Broadest product portfolio across home medical subcategories 4.1-4.9; overseas revenue surged 29.86% to ¥1.232B in 2025; massive R&D investment in CGM and next-gen health monitors; global manufacturing network spanning China, Germany, USA, and Taiwan.
Weaknesses: Net profit dropped 17.94% due to aggressive marketing spend (¥1.763B sales expenses); faces intense domestic price competition; brand recognition still lower than Western incumbents outside China.
Listed market data
002223 · SZSE · weeklyHistory →- Market cap
- $3.8 B
- Share price
- ≈ CNY 3.77
- 1Y change
- -24.2%
- Recent change
- +6.8%
- IPO price
- ×13.6
- Revenue (TTM)
- ¥8 B
10-22 → 10-23
CNY 9.48 · from 2008-04-18
Financial history
Full market history- 2026-10CNY 27.31$3.8 B+4.0%
- 2026-09CNY 26.27$3.6 B+1.1%
- 2026-08CNY 25.98$3.6 B-7.5%
- 2026-07CNY 28.08$3.9 B+9.4%
- 2026-06CNY 25.66$3.5 B-2.9%
- 2026-05CNY 26.43$3.6 B-9.7%
- 2026-04CNY 29.28$4 B-13.6%
- 2026-03CNY 33.90$4.7 B-12.4%
- 2026-02CNY 38.70$5.3 B-3.0%
- 2026-01CNY 39.90$5.5 B+4.4%
- 2025-12CNY 38.21$5.3 B+7.0%
- 2025-11CNY 35.70$4.9 B—
In the press
All coverage →5 latest headlines- GC Medical Science, Yuwell Target CGM Market - Businesskoreawww.businesskorea.co.kr2026-10-14
- GC Biopharma MS Partners With China's Yuwell on Glucose Monitors - Seoul Economic Dailyen.sedaily.com2026-10-14
- GC MS partners with China’s Yuwell to launch continuous glucose monitor in Korea - CHOSUNBIZ - Chosunbizbiz.chosun.com2026-10-14
- Yuwell AT5 Pro Operation Video - YouTubeyoutu.be2026-06-06
- HME partners with Yuwell, adds respiratory to portfolio - HME Newswww.hmenews.com2026-03-18
• Home oxygen concentrators and respiratory therapy devices
• Blood glucose monitors and developing CGM systems
• Digital blood pressure monitors for home use
• Home-use ventilators and CPAP devices
• First aid and emergency medical products including AEDs
• Rehabilitation and physical therapy equipment
• Family care and personal health monitoring devices
Quick Facts
Headquarters
Shanghai, China
Founded
1998
Employees
12000+
Revenue
¥8 B
Market cap
$3.8 B
Factories
5+ factories in 4 countries
Listing
SZSE: 002223
Categories
Related
Similar listed companies
- Nvidia Corporation· $5.2 T
- Micron Technology, Inc.· $994 B
- Johnson & Johnson (J&J)· $616 B
- Allergan Aesthetics· $504 B
- Intel Corporation· $475 B
- F. Hoffmann-La Roche AG· $372 B
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Official Website SZSE: 002223 , Data Sources & Methodology
Yuwell Official Website
Yuwell 2025 Revenue - Beijing News
Yuwell 2025 Financial Analysis
Yuwell 2025 Annual Report Highlights